MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical-stage genetic medicines company, today announced that the Compensation Committee of the Company’s Board of Directors approved ...
Medtide (HKEX: 03880.HK) is a global CRDMO company specializing in peptides and oligonucleotides. Originally founded as Chinese Peptide Company in 2001, the company has accumulated over 25 years of ...
Completed GMP manufacturing and toxicology milestones supporting planned Q4 2026 IND submission for ulcerative colitisExpanded pipeline strategy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results